The REDCap consortium: building an international community of software platform partners
Open accessAbstract
The Research Electronic Data Capture (REDCap) data management platform was developed in 2004 to address an institutional need at Vanderbilt University, then shared with a limited number of adopting sites beginning in 2006. Given bi-directional benefit in early sharing experiments, we created a broader consortium sharing and support model for any academic, non-profit, or government partner wishing to adopt the software. Our sharing framework and consortium-based support model have evolved over time along with the size of the consortium (currently more than 3,200 REDCap partners across 128 countries). While the “REDCap Consortium” model represents only one example of how to build and disseminate a software platform, lessons learned from our approach may assist other research institutions seeking to build and disseminate innovative technologies.
AI snapshot
Written from the paper’s full text.
TL;DR
This paper describes how REDCap grew from a Vanderbilt-built data capture tool into an international consortium through phased sharing and support. It reports that by mid-December 2018 the consortium had more than 3,200 partners in 128 countries and argues that the staged model offers transferable lessons for disseminating research software.
Key findings
- The consortium expanded from a single site in 2004–2005 to more than 3,207 partners across 128 countries by mid-December 2018; in 2018 alone it added 575 partners, with roughly 2.75 international requests for each U.S. request and more than 20% of partners in World Bank low- and middle-income countries.
- Growth followed six phases: local development, three collaborating sites, 4–10 partners, about 50 national sites, about 500 sites, and then more than 500 sites globally, with changes in licensing, communication, support staffing, and feature priorities at each stage.
- REDCap was cited in more than 6,000 journal articles between 2004 and 2018; early return-on-investment tracking at Vanderbilt in 2008–2009 cited REDCap’s value in securing 23 funded or awarded projects.
- Lessons include starting with local needs, maintaining compatibility with existing projects, setting modest expectations and delivering more than promised, using simple communication tools, managing growth deliberately, and enabling flexible modules, APIs, and plug-ins.
Methods
- Descriptive experience report tracing REDCap and the REDCap Consortium from 2004 through 2018, organized into six chronological phases.
- Evidence includes consortium membership counts, partner distribution, publication citation counts, local return-on-investment examples, and narrative accounts of governance, licensing, support calls, conferences, and software features.
- No formal hypothesis testing or controlled comparison; the analysis is a retrospective narrative synthesis of program metrics and lessons learned.
Limitations
- Stated: the authors note that the REDCap Consortium is only one dissemination model and may not suit all groups; REDCap is not open source, eligibility is limited to non-profit or government institutions, the license restricts code sharing and reseller services, and Vanderbilt retains control over the development trajectory and funding-driven priorities.
- Stated: growth reduced Vanderbilt’s ability to maintain close ties with every new partner; support is limited to partner informatics teams rather than end users, and many non-technical vendor requests were denied.
- Evident: the metrics are program-reported and descriptive, with no independent or controlled evaluation; citation counts and return-on-investment examples are not adjusted for confounding, and the paper does not report systematic user outcomes or comparative performance against other platforms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
12 of 20 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured
- Premisecitation
REDCap is an example of a CTSA-funded clinical research software application that has grown beyond its single institutional use case to be shared with institutions across the world.
“The Research Electronic Data Capture (REDCap) data management platform is an example of a CTSA-funded clinical research software application that has grown beyond its single institutional use case to be shared with institutions across the world [26].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [26] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support, J. Biomed. Inform 42 (2009) 377– 381. doi: 10.1016/j.jbi.2008.08.010. 18929686 PMC2700030 source
The Introduction says REDCap was initially developed at Vanderbilt, and Results IV.B reports that it was shared through a consortium of 26 domestic and one international partner. Results IV.A links REDCap to a CTSA organization, but the passages do not establish that CTSA funded the software. The reported international reach is also narrower than “institutions across the world” may suggest. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
There remain significant barriers to sharing clinical research software applications.
“there remain significant barriers to sharing clinical research software applications [19]”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [19] Reis SE, Berglund L, Bernard GR, Califf RM, Fitzgerald GA, Johnson PC, Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium, Acad. Med. J. Assoc. Am. Med. Coll 85 (2010) 463– 469. doi: 10.1097/ACM.0b013e3181ccc877. PMC2829722 20182119 source
The Abstract (page not provided) describes barriers to collaboration in translational research, and Strategic Goal 3 proposes data-sharing mechanisms across the consortium. Neither passage identifies significant barriers to sharing clinical research software applications specifically. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Premisecitation
Limited personnel and resources are stretched to support research needs, forcing sites to restrict programs and services and limit innovation.
“limited personnel and resources are stretched to support research needs, forcing sites to restrict programs and services and limit innovation [6–9].”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [6] May L, Zatorski C, Vora D, The Role of Technology in Translational Science, World Med. Health Policy 5 (2013) 389– 394. doi: 10.1002/wmh3.69. source
- cites [7] Fahy BG, Balke CW, Umberger GH, Talbert J, Canales DN, Steltenkamp CL, Conigliaro J, Crossing the chasm: information technology to biomedical informatics, J. Investig. Med. Off. Publ. Am. Fed. Clin. Res 59 (2011) 768– 779. doi: 10.231/JIM.0b013e31821452bf. PMC3137749 21383632 source
The Discussion (Barriers; page unavailable) describes funding constraints, unevenly distributed resources, and reliance on IT personnel outside the program to meet research needs. It does not say these pressures forced sites to restrict programs or services or limited innovation; the program described instead obtained funding to expand its capabilities. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [8] Sheetz MP, Can small institutes address some problems facing biomedical researchers?, Mol. Biol. Cell 25 (2014) 3267– 3269. doi: 10.1091/mbc.E14-05-1017. 25360047 PMC4214771 source
The Introduction describes funding difficulties and increasing regulatory demands, while “Funding of Small Institutes” says flexible funds are critical to innovative research. The paper does not say that limited personnel and resources force sites to restrict programs or services; its account instead focuses on how shared staff and facilities can support research. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [9] Etz RS, Hahn KA, Gonzalez MM, Crabtree BF, Stange KC, Practice-Based Innovations: More Relevant and Transportable Than NIH-funded Studies, J. Am. Board Fam. Med 27 (2014) 738– 739. doi: 10.3122/jabfm.2014.06.140053. 25381069 source
The paper’s table (page not provided) says research grants often add responsibilities to existing jobs, and its discussion describes practices adapting to funding constraints. It does not say that supporting research forces sites to restrict programs or services, or that personnel demands limit innovation. (LLM, conf=0.81)
Experimental — accuracy not yet measured
- Findingown data
Since its initial development at Vanderbilt University, REDCap has been adopted by more than 3,207 partners in 128 countries as of mid-December 2018.
“Since its initial development at Vanderbilt University, REDCap has been adopted by more than 3,207 partners in 128 countries as of mid-December 2018 (Figures 1 and 2, Table 1).”
Quote in the paperNot a substantial claim - Findingnone given
The authors created a broader consortium sharing and support model for any academic, non-profit, or government partner wishing to adopt the software.
“we created a broader consortium sharing and support model for any academic, non-profit, or government partner wishing to adopt the software”
Quote in the paperSubstantial claim
- Findingown data
During 2008 and 2009, Vanderbilt local research teams cited REDCap's value in securing 23 new funded/awarded projects across numerous biomedical research areas.
“During 2008 and 2009, our earliest phase of formally tracking return on investment for REDCap support at Vanderbilt, our local research teams cited REDCap’s value in securing 23 new funded/awarded projects across numerous biomedical research areas”
Quote in the paperNot a substantial claim - Findingown data
The REDCap platform is used at Vanderbilt and across REDCap Consortium partner institutions for many other use cases, including operational support, quality improvement projects, and as a sub-component for larger systems and workflow architecture.
“the platform is used at Vanderbilt and across REDCap Consortium partner institutions for many other use cases (Figure 4), including operational support, quality improvement projects, and even as a sub-component for larger systems and workflow architecture.”
Quote in the paperNot a substantial claim - Findingcitation
More than six thousand journal articles cited use of the software platform in conducting studies between 2004 and 2018.
“More than six thousand journal articles have cited use of the software platform in conducting studies during the period between 2004 and 2018 [60].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Citations – REDCap, (n.d.). https://projectredcap.org/resources/citations/ (accessed December 17, 2018). source
- Findingreasoning
Developing formal installation documentation placed a high burden on the Vanderbilt REDCap group.
“Developing formal installation documentation placed a high burden on the Vanderbilt REDCap group, as we had to design a generalizable resource while responding to many customized support requests from adopting institutions.”
Quote in the paperNot a substantial claim - Findingnone given
REDCap was developed in 2004 to provide Vanderbilt University clinical and translational researchers with a straightforward approach to create data management plans while implementing a secure, compliant data management system for their research studies.
“REDCap was developed in 2004 to provide Vanderbilt University clinical and translational researchers with a straightforward approach to create data management plans while implementing a secure, compliant data management system for their research studies.”
Quote in the paperNot a substantial claim - Findingnone given
Extracting REDCap code for use at other institutions required time and effort.
“Extracting REDCap code for use at other institutions required time and effort.”
Quote in the paperSubstantial claim - Premisereasoning
Sharing can produce bi-directional benefits.
“sharing can produce bi-directional benefits.”
Quote in the paperNot a substantial claim - Premisecitation
Reductions in grant funding and restricted institutional budgets have diminished the ability of many clinical organizations to hire and retain operations-focused CRI faculty and staff.
“reductions in grant funding and restricted institutional budgets have diminished the ability of many clinical organizations to hire and retain operations-focused CRI faculty and staff [4,5].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [4] Pober JS, Neuhauser CS, Pober JM, Obstacles facing translational research in academic medical centers, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol 15 (2001) 2303– 2313. doi: 10.1096/fj.01-0540lsf. 11689456 source
- cites [5] Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D, Central challenges facing the national clinical research enterprise, JAMA. 289 (2003) 1278– 1287. 12633190 source
- Interpretationnone given
The Vanderbilt team has created platform features (e.g., restful API services, sustained plug-in architecture) that enable any REDCap Consortium partner to build and share 'add-on' features necessary to support individual study needs.
“we have created platform features (e.g., restful API services, sustained plug-in architecture) that enable any REDCap Consortium partner to build and share ‘add-on’ features that might be necessary to support individual study needs.”
Quote in the paperSubstantial claim - Interpretationnone given
The licensing model provided a stable source of software development funding independent from grant-driven requirements.
“This provided a stable source of software development funding that was independent from grant-driven requirements.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The mixed funding model requires prioritizing development in areas consistent with larger funding initiatives.
“The mixed funding model we use to support REDCap also requires that we prioritize development in areas consistent with the larger funding initiatives”
Quote in the paperNot a substantial claim - Interpretationcitation
A large partnership has made it possible to gain attention and support to build integration and interoperability with other software platforms and cloud-based ecosystems.
“A large partnership has made it possible to gain attention and support to build integration and interoperability with other software platforms and cloud-based ecosystems [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] This repository contains AWS CloudFormation templates to automatically deploy a REDCap environment that adheres to AWS architectural best practices: vanderbilt-redcap/redcap-aws-cloudformation, Vanderbilt REDCap Group, 2018 https://github.com/vanderbilt-redcap/redcap-aws-cloudformation (accessed December 17, 2018).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The need for additional communication mechanisms increased the need for administrative support.
“The need for additional communication mechanisms (e.g., persistent forum software vs. simple listservs, dedicated monthly consortium calls for Europe/Africa and Asia/Oceania time zones, expanded educational content for annual REDCap conference) increased need for administrative support.”
Quote in the paperNot a substantial claim - Interpretationown data
Given the Consortium growth rate, the Vanderbilt team could no longer maintain a close connection to each new partner site.
“Given the Consortium growth rate, the Vanderbilt team could no longer maintain a close connection to each new partner site”
Quote in the paperSubstantial claim - Interpretationreasoning
The increasing international partner base in resource-limited areas prompted the teams to build a REDCap mobile app to allow offline data collection when internet connectivity is not present.
“Our increasing international partner base in resource-limited areas has prompted our teams to build a REDCap mobile app to allow offline data collection when internet connectivity is not present.”
Quote in the paperSubstantial claim - Interpretationown data
Bibliometric capture and analysis methods provide evidence of value for REDCap in diverse scientific research domains.
“While bibliometric capture and analysis methods (Figure 3) provide evidence of value for REDCap in diverse scientific research domains”
Quote in the paperNot a substantial claim - Interpretationcitation
Regional relevance has prompted several international partners to organize and self-fund regional annual or biannual REDCap conferences.
“Regional relevance (e.g., having many REDCap partners in a single country or geographic region) has prompted several of our international partners to organize and self-fund regional annual or biannual regional REDCap conferences [58,59].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [58] Japan REDCap Consortium - JREC - - Home, (n.d.). https://www.facebook.com/japan.redcap/ (accessed December 17, 2018).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [59] First Latin American and Brazilian REDCapCon, (n.d.). http://www.redcapbrasil.com.br/redcapcon/en/redcapcon/en/ (accessed December 17, 2018).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Many institutional leaders showed greater willingness to adopt software with a closed codebase, given the sensitive nature of the data stored on REDCap platforms and the perceived security risk of open source code.
“Many institutional leaders showed greater willingness to adopt software with a closed codebase, given the sensitive nature of the data stored on REDCap platforms (such as individually identifiable health information) and the perceived security risk of open source code.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The growth of the REDCap Consortium and user base has created opportunities to collaborate with other consortia to integrate standardized terminologies and instruments.
“The growth of the REDCap Consortium and user base has created opportunities to collaborate with other consortia (e.g., PhenX [52,53], Medical Data Models [54], BioPortal [55], PROMIS [56]) to integrate standardized terminologies and instruments.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The licensing model ensured REDCap's sustainability as a software platform.
“Finally, this licensing model ensured REDCap’s sustainability as a software platform.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 42
- May combine two claims. 25
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
PremisecitationClinical research informatics (CRI) is an evolving field widely recognized as crucial for transforming and reengineering the translational research enterprise.
“Clinical research informatics (CRI) is an evolving field widely recognized as crucial for transforming and reengineering the translational research enterprise [1–3].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [1] Embi PJ, Clinical research informatics: survey of recent advances and trends in a maturing field, Yearb. Med. Inform 8 (2013) 178– 184. 23974569 source
- cites [2] Embi PJ, Payne PRO, Advancing methodologies in Clinical Research Informatics (CRI): Foundational work for a maturing field, J. Biomed. Inform 52 (2014) 1– 3. doi: 10.1016/j.jbi.2014.10.007. 25484113 source
The opening passage (page unavailable) describes CRI as an emergent field with growing activity in response to challenges in translational clinical research. Later passages say CRI methods can accelerate research and improve its conduct, but do not establish that CRI is widely recognized as crucial for transforming and reengineering the translational research enterprise. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [3] Kahn MG, Weng C, Clinical research informatics: a conceptual perspective, J. Am. Med. Inform. Assoc 19 (2012) e36– e42. doi: 10.1136/amiajnl-2012-000968. 22523344 PMC3392857 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationREDCap has limited personnel requirements (one support person can easily manage hundreds of projects) but does require typical web infrastructure including one or more secure web servers running PHP, MySQL/MariaDB, and SMTP email services.
“REDCap has limited personnel requirements (one support person can easily manage hundreds of projects [48]) but does require typical web infrastructure including one or more secure web servers running PHP, MySQL/MariaDB, and SMTP email services.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [48] Klipin M, Mare I, Hazelhurst S, Kramer B, The process of installing REDCap, a web based database supporting biomedical research: the first year, Appl. Clin. Inform 5 (2014) 916– 929. doi: 10.4338/ACI-2014-06-CR-0054. 25589907 PMC4287671 source
The citation is attached to the personnel claim. The Methods section reports three staff with allocated REDCap time, and §4.2 reports 133 projects; these support modest staffing needs, but not the assertion that one support person can easily manage hundreds of projects. The subsequent infrastructure claim is outside the cited parenthetical. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlternate software distribution models exist (e.g., i2b2, OpenMRS, Vivo).
“Alternate software distribution models exist (e.g., i2b2 [61], OpenMRS [62], and Vivo [63])”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [61] Natter MD, Quan J, Ortiz DM, Bousvaros A, Ilowite NT, Inman CJ, Marsolo K, McMurry AJ, Sandborg CI, Schanberg LE, Wallace CA, Warren RW, Weber GM, Mandl KD, An i2b2-based, generalizable, open source, self-scaling chronic disease registry, J. Am. Med. Inform. Assoc. JAMIA 20 (2013) 172– 179. doi: 10.1136/amiajnl-2012-001042. 22733975 PMC3555330 source
- cites [62] Mohammed-Rajput NA, Smith DC, Mamlin B, Biondich P, Doebbeling BN, OpenMRS A Global Medical Records System Collaborative: Factors Influencing Successful Implementation, AMIA. Annu. Symp. Proc 2011 (2011) 960– 968. 22195155 PMC3243141
- cites [63] Borner K, Ding Y, Conlon M, Corson-Rikert J, VIVO: A Semantic Approach to Scholarly Networking and Discovery, Morgan & Claypool Publishers, 2012. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationREDCap is a secure web application for building and managing online surveys and databases, designed to support data capture for research studies.
“REDCap is a secure web application for building and managing online surveys and databases, designed to support data capture for research studies [26].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [26] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support, J. Biomed. Inform 42 (2009) 377– 381. doi: 10.1016/j.jbi.2008.08.010. 18929686 PMC2700030 source
The Methods sections on study creation and the user interface describe REDCap as a secure, web-based application for creating study databases and collecting research data through electronic forms. The passages do not establish that it builds or manages online surveys specifically. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenREDCap was developed in 2004 to address an institutional need at Vanderbilt University.
“The Research Electronic Data Capture (REDCap) data management platform was developed in 2004 to address an institutional need at Vanderbilt University”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenREDCap was shared with a limited number of adopting sites beginning in 2006.
“then shared with a limited number of adopting sites beginning in 2006”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe sharing framework and consortium-based support model have evolved over time along with the size of the consortium.
“Our sharing framework and consortium-based support model have evolved over time along with the size of the consortium”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenCurrently more than 3,200 REDCap partners across 128 countries.
“currently more than 3,200 REDCap partners across 128 countries”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe Vanderbilt team maintains control of the REDCap software development trajectory, although it frequently seeks input on features and prioritization from the Consortium.
“The Vanderbilt team also maintains control of the REDCap software development trajectory, although we frequently seek input on features and prioritization from the Consortium.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenVanderbilt's IRB system uses REDCap as a central component for protocol submissions.
“Vanderbilt’s IRB system uses REDCap as a central component for protocol submissions”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe Vanderbilt REDCap team expanded its staffing to five full-time developers and two dedicated community support people, with additional associated faculty and custom add-on developers from the Data Core.
“the Vanderbilt REDCap team has expanded its staffing to five full-time developers and two dedicated community support people, with the addition of other associated faculty and custom add-on developers from the Data Core.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenA "zero-fee" REDCap Consortium membership meant we could only provide support to our partners' informatics teams, not their end users.
“a “zero-fee” REDCap Consortium membership meant we could only provide support to our partners’ informatics teams, not their end users.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningBy mid-2006, the three-site REDCap collaborative had proven so productive that we decided to establish a true consortium by expanding to ten sites.
“By mid-2006, the three-site REDCap collaborative established in Phase 2 had proven so productive that we decided to establish a true consortium by expanding to ten sites.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenBy the end of 2012, we were supporting more than 500 Consortium partners.
“By the end of 2012, we were supporting more than 500 Consortium partners.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenInterest in REDCap spiked once approximately 50 partners had joined the Consortium and membership trended upwards in 2009.
“Interest in REDCap spiked once approximately 50 partners had joined the Consortium and membership trended upwards in 2009.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAdditional partners meant more time spent managing groups and less time working on needs specific to Vanderbilt research teams.
“Additional partners meant more time spent managing groups and less time working on needs specific to Vanderbilt research teams.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenFunding support for REDCap has become increasingly diverse, including institutional sources, CTSA, Vanderbilt Data Core model, and other NIH-funded grants.
“Funding support for REDCap has become increasingly diverse, including support from institutional sources, the CTSA, the Vanderbilt Data Core model, and other NIH-funded grants.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenConsortium members continue to provide cross-institutional support through sharing resources, participating in formal presentations, and contributing to Consortium Committees.
“Consortium members continue to provide cross-institutional support for one another through sharing resources (e.g., end-user local training material repository), participating in formal presentations (e.g., monthly REDCapU sessions design to support REDCap domain knowledge and career growth of local informatics champions), and contribution to Consortium Committees.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenMinor revisions to the REDCap EULA have clarified licensing for non-U.S. partners and cloud-based installations.
“Minor revisions to the REDCap EULA have clarified licensing for non-U.S. partners and cloud-based installations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenMore than 20% of REDCap partners are located in countries designated as low-and middle-income by the World Bank.
“More than 20% of REDCap partners are now located in countries designated as low-and middle-income by the World Bank.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenFor-profit software vendors began to regard the REDCap community as a potential market, attempting to sell alternate software solutions.
“For-profit software vendors also began to regard the REDCap community as a potential market, attempting to sell alternate software solutions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Findingnone givenBy 2005, REDCap adoption had accelerated at Vanderbilt and we learned that other institutions faced the same challenge supporting their local research communities with centralized, HIPAA-compliant solutions for data planning, collection, and management.
“By 2005, REDCap adoption had accelerated at Vanderbilt and we learned that other institutions faced the same challenge supporting their local research communities with centralized, HIPAA-compliant solutions for data planning, collection, and management.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenVanderbilt's research data warehousing teams have built system exchange mechanisms allowing REDCap to serve as a final data delivery mechanism.
“our research data warehousing teams have built system exchange mechanisms allowing REDCap to serve as a final data delivery mechanism.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningPCORI grant initiatives led to many features and functions necessary for participant engagement and patient reported data.
“PCORI grant initiatives led to many features and functions necessary for participant engagement and patient reported data”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenNew Committees have formed around shareable training materials, software plug-in development, and electronic health record systems integration.
“New Committees have formed around shareable training materials, software plug-in development, and electronic health record systems integration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenREDCap Consortium partner distribution tends to correlate with population density and regions of the world where biomedical research is supported.
“In general, REDCap Consortium partner distribution tends to correlate with population density and regions of the world where biomedical research is supported.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningVanderbilt resources were limited and the effort of supporting partner sites resulted in an overall slowdown of feature programming as well as local end-user training and promotion.
“Vanderbilt resources were limited and the effort of supporting partner sites resulted in an overall slowdown of feature programming as well as local end-user training and promotion.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenIn 2018, 575 new REDCap partners were added, with approximately 2.75 international members for each U.S. request.
“In 2018 alone, we added 575 new REDCap partners with approximately 2.75 international members for each U.S. request.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenREDCap partner institutions have gradually increased adoption of virtualized environments running REDCap, and more recently containerized solutions.
“we have observed a gradual increase among REDCap partner institutions adopting virtualized environments running REDCap, and in more recent years, containerized solutions for supporting the software platform.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningEmpowering local research teams to create and manage their own REDCap projects reduced per-project cost and ultimately allowed Vanderbilt to provide REDCap at no cost to any student, staff, or faculty member for any research project.
“Empowering local research teams to create and manage their own REDCap projects reduced per-project cost and ultimately allowed Vanderbilt to provide REDCap at no cost to any student, staff, or faculty member for any research project.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Findingnone givenThe number of REDCap end users has grown proportionately, creating additional demand for generalized REDCap training.
“The number of REDCap end users has grown proportionately, creating additional demand for generalized REDCap training.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe paper EULA documents required signature by institutional officials on both sides, which introduced a two-to-three-week administrative turnaround time for joining the Consortium.
“The paper EULA documents required signature by institutional officials on both sides, which introduced a two-to-three-week administrative turnaround time for joining the Consortium.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenExperts in various domains participate in the consortium and consult with the development team as needed.
“Experts in informatics, biostatistics, data warehousing, clinical systems, trial operations, standards and ontologies, security methods, computer science, global health, mobile systems, library science, and other domains participate in the consortium and consult with the development team as needed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenGroups that were not proactive in their use of the Consortium mailing list were less likely to integrate with the existing community.
“groups that were not proactive in their use of the Consortium mailing list were less likely to integrate with the existing community.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenOrganizations that adopted REDCap during Phase 4 were typically U.S.-based academic medical centers, though we also began working with a few highly motivated international partners from Japan, Singapore, and Canada.
“Organizations that adopted REDCap during this Phase were typically U.S.-based academic medical centers, though we also began working with a few highly motivated international partners from Japan, Singapore, and Canada.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe Core model enabled us to provide hosting services to users outside of Vanderbilt whose needs went beyond standard REDCap infrastructure, allowed diversification of our financial support model, and introduced the REDCap platform to more diverse users (including industry based research teams).
“The Core model enabled us to provide hosting services to users outside of Vanderbilt whose needs went beyond standard REDCap infrastructure, allowed diversification of our financial support model, and introduced the REDCap platform to more diverse users (including industry based research teams).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenDuring the 2014 Ebola outbreak, REDCap partner sites rapidly mobilized to share methods for surveillance data collection in academia and state governments, setting the stage for additional attention and adoption across U.S. state health departments, the U.S. Department of Veterans Affairs and other government agencies.
“During the Ebola outbreak in 2014, we saw a rapid mobilization of REDCap partner sites sharing methods for surveillance data collection in both academia and state governments, setting the stage for additional attention and adoption across U.S. state health departments, the U.S. Department of Veterans Affairs and other government agencies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenKey features of the REDCap model have been early strategic partnering followed by managed growth and support of the community in stages.
“Key features of the model have been early strategic partnering followed by managed growth and support of our community in stages.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenNew telephone and SMS-based survey features, offline functionality via the REDCap mobile application for coordinators, and MyCap for participants have enabled research data collection in settings unsuited to traditional web-based applications.
“New telephone and SMS-based survey features, “offline” functionality via the REDCap mobile application for coordinators, and a separate mobile application (MyCap, https://www.projectmycap.org) for participants have enabled research data collection in settings unsuited to traditional web-based applications.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningCore components of the REDCap model may not be suited to all groups.
“core components of our model may not be suited to all groups.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenREDCap is available at no cost but is not open source software.
“although REDCap is available at no cost, it is not open source software.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenREDCap's back-end architecture runs on open source components, is very flexible, and does not force strict requirements for general implementation.
“REDCap’s back-end architecture, all of which runs on open source components, is very flexible and does not force strict requirements for general implementation.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenThe REDCap model has been successful to date, growing from a single site to a global consortium over approximately 13 years.
“The REDCap model has been successful to date, growing from a single site to a global consortium over the course of approximately 13 years.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenPortability of project metadata across REDCap installations has allowed new types of sharing and collaboration.
“Portability of project metadata across REDCap installations has allowed new types of sharing and collaboration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningAs the Consortium has grown, the sophistication and influence of Consortium partners has increased.
“As the Consortium has grown, so has the sophistication and influence of our Consortium partners.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenThe REDCap Consortium has proven a successful model for software development and dissemination.
“The REDCap Consortium has proven a successful model for software development and dissemination.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningBy limiting Consortium membership to non-profit and government organizations, Vanderbilt reserved the right to market REDCap in the commercial space and to perform fee-based hosting for research teams in organizations not able or willing to join the REDCap consortium.
“By limiting Consortium membership to non-profit and government organizations, Vanderbilt reserved the right to market REDCap in the commercial space and also to perform fee-based hosting for research teams in organizations not able or willing to join the REDCap consortium.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningRecent work with major cloud vendors on deployment scripts and automated REDCap upgrade methods have created an opportunity for partners to set up REDCap installations in the cloud, eliminating the need for on-site hardware and reducing local systems administrator support.
“Recent work with major cloud vendors on deployment scripts and automated REDCap upgrade methods have created an opportunity for partners to set up REDCap installations in the cloud, thereby eliminating the need for on-site hardware and reducing local systems administrator support.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningSoftware feature requests and guidance from active research teams have enabled the platform to grow from a rudimentary feature set to a rich set of modules capable of supporting diverse research operations on almost any scale.
“Software feature requests and guidance from active research teams have enabled the platform to grow from a rudimentary feature set (data capture, data export, logging) to a rich set of modules capable of supporting diverse research operations on almost any scale.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningREDCap can operate on-premise or on various cloud-based infrastructures (e.g., AWS, Azure, Google Cloud).
“REDCap can operate “onpremise” (on the local institution’s hardware servers or virtualized servers) or on various cloud-based infrastructures (e.g., AWS, Azure, Google Cloud).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe REDCap platform and Consortium represent only a single model in terms of software development and dissemination.
“The REDCap platform and Consortium represent only a single model in terms of software development and dissemination.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningEligible REDCap partners must be non-profit or government institutions (not individuals), comply with U.S. export regulations, and agree to EULA terms including not sharing the codebase with third parties and not offering REDCap "reseller" services.
“Eligible partners must be non-profit or government institutions (not individuals), comply with U.S. export regulations, and agree to the EULA terms, which include not sharing the codebase with third parties and not offering REDCap “reseller” services.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenThe REDCap software development and consortium growth model have been successful.
“While the REDCap software development and consortium growth model have been successful”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe iterative software design philosophy and incremental consortium growth fostered a collaborative spirit during REDCap's early days, which has been sustained through active participation of thousands of REDCap administrators.
“The iterative software design philosophy and incremental consortium growth fostered a collaborative spirit during REDCap’s early days, which has been sustained through the active participation of thousands of REDCap administrators in REDCap calls, mailing lists, working groups, and conferences.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The core principles of the REDCap Consortium model are generalizable to other software development teams or sharing consortia.
“we believe the core principles are generalizable and can benefit any software development team or sharing consortium.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The randomization table will be generated by an external researcher, who will be the only one with access to the original randomization table; enrolment and the generation of the allocation code will be automatized via REDCap and cannot be influenced by any member of the research team.
“The randomization table providing the basis for the computerized allocation in REDCap [182, 183] will be generated by an external researcher, who will be the only one with access to the original randomization table. Enrolment and the generation of the allocation code will be automatized via REDCap [182, 183] and hence cannot be influenced by any member of the research team.”
From Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial (2024) · cites this paper as [183]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredREDCap provides user-level access control, and changes with username, date, time, and modification are logged (audit trail) and can be controlled at any time.
“REDCap [182, 183] will be used for data collection (interviews, online surveys). It provides user-level access control as it is only accessible to authorized personnel. To ensure traceability of relevant processing operations, changes with username, date, time, and modification are logged (audit trail) and can be controlled at any time.”
From Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial (2024) · cites this paper as [183]
The Phase 1 section (page not provided) identifies user-rights functionality and extensive data and operations logging, supporting access control and a general audit trail. It does not specify that each change is logged with a username, date, time, and modification, or that the log can be checked at any time. (LLM, conf=0.88)
Experimental — accuracy not yet measuredRandomization was conducted using REDCap's randomization function with a 1:1 allocation ratio to MB-P or usual prenatal care.
“pregnant individuals were assigned using REDCap’s randomization function via a 1:1 allocation ratio to MB-P or usual prenatal care.”
From Effects of a Personalized Stress Management Intervention on Maternal Mental Health: A Randomized Clinical Trial. (2025) · cites this paper as Harris et al. 2019
The Phase 5 section (no page provided) says REDCap developed a participant-randomization module, supporting the reference to REDCap’s randomization function. It does not report the MB-P prenatal trial, its participants, or a 1:1 allocation to MB-P versus usual care. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe randomization sequence was created by a statistician unaffiliated with the study to ensure masking to the randomization scheme and was implemented by REDCAP's randomization software based on the participant's location.
“This randomization sequence was created by a statistician unaffiliated with the study to ensure masking to the randomization scheme and was implemented by REDCAP’s randomization software based on the participant’s location52,53.”
From Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial (2024) · cites this paper as [52]
The Phase 5 section says REDCap added a participant-randomization module, supporting the identification of REDCap as randomization software. It does not describe this study’s sequence, an unaffiliated statistician, masking, or randomization based on participant location; searches for those details found no supporting passage. No page number is available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured118 additional families completed a REDCap screening form but were not enrolled.
“118 additional families completed a REDCap (Research Electronic Data Capture, [51,52]) screening form but were not enrolled.”
Signed informed consent was obtained from all participants via REDCap.
“Signed informed consent was obtained from all participants via REDCap (Vanderbilt University, Nashville, TN) [25, 26].”
From Recruitment, retention and recouperation: lessons learned from a study aimed at assessing burnout mitigation in physician learners (2025) · cites this paper as [26]
The randomization table will be uploaded to REDCap by a REDCap administrator from the Clinical Trials Unit and will become inaccessible for the external researcher who generated it and remain inaccessible for the research team.
“The randomization table will be uploaded to the web-based Research Electronic Data Capture (REDCap) [182, 183] by a REDCap administrator from the Clinical Trials Unit. Afterwards, it will become inaccessible for the external researcher who generated the randomization table and remain inaccessible for the research team.”
From Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial (2024) · cites this paper as [183]
After baseline measures, participants are randomized to one of the two conditions by a research assistant who does not conduct assessments, using computerized randomization (REDCAP).
“After baseline measures (T1) participants are randomized to one of the two conditions by a research assistant who does not conduct assessments, using computerized randomization (REDCAP) [53, 54].”
Allocation concealment will be ensured as the allocation code will not be visible to the research team before a participant has been assigned to one of the treatment conditions.
“Allocation concealment will be ensured as the allocation code will not be visible to the research team before a participant has been assigned to one of the treatment conditions.”
From Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial (2024) · cites this paper as [183]
The Phase 5 section says REDCap added a participant-randomization module, but it does not describe allocation-code visibility or concealment before assignment. Searches for allocation concealment, allocation codes, and randomization found no passage establishing the claimed procedure. (LLM, conf=0.74)
Experimental — accuracy not yet measuredThe randomization sequence list was kept in REDCap, preventing the research team from anticipating the next allocation, and data were released after baseline data collection.
“The sequence list was kept in Research Electronic Data Capture software [22], preventing the research team from anticipating to which arm the next participant would be allocated. Data were released after the baseline data collection was completed.”
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 4× · see citing works
“The REDCap system data architecture was originally flat, using a set of five replicable database tables for each project as previously described (for scalability, we later moved to an entity-attribute-value data model utilizing global tables in a single MySQL database) [26].”
BackgroundMethodInfluentialSelf-citationCentral challenges facing the national clinical research enterprise
Sung, N. S., Crowley, W. F., Genel, M., Salber, P., Sandy, L., Sherwood, L. M., Johnson, S. B., Catanese, V., Tilson, H., Getz, K., et al. (2003) · JAMA · doi:10.1001/jama.289.10.1278 · Cited by 1,235 · see citing works
Whetzel, P. L., Noy, N. F., Shah, N. H., Alexander, P. R., Nyulas, C. I., Tudorache, T., & Musen, M. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr469 · Cited by 793 · cited 1× · see citing works
“The growth of the REDCap Consortium and user base has created opportunities to collaborate with other consortia (e.g., PhenX [52,53], Medical Data Models [54], BioPortal [55], PROMIS [56]) to integrate standardized terminologies and instruments.”
BackgroundLaunching PCORnet, a national patient-centered clinical research network
Fleurence, R., Curtis, L. H., Califf, R. M., Platt, R., Selby, J. V., & Brown, J. S. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002747 · Cited by 637 · see citing works
Procurement of shared data instruments for Research Electronic Data Capture (REDCap)
Obeid, J. S., McGraw, C. A., Minor, B. L., Conde, J. G., Pawluk, R., Lin, M. K., Wang, J., Banks, S. R., Hemphill, S. A., Taylor, R., et al. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.10.006 · Cited by 285 · cited 1× · see citing works
“We created a “shared instrument library” where REDCap users at any institution could download and use REDCap-reviewed versions of validated data collection instruments [51].”
MethodSelf-citationGlobal software development and collaboration : barriers and solutions
Noll, J., Beecham, S., & Richardson, I. (2010) · University of Limerick Institutional Repository (University of Limerick) · doi:10.34961/9505 · Cited by 275 · see citing works
Bevans, M. F., Ross, A. C., & Cella, D. F. (2014) · Nursing Outlook · doi:10.1016/j.outlook.2014.05.009 · Cited by 242 · see citing works
Critically Ill Children During the 2009–2010 Influenza Pandemic in the United States
Randolph, A. G., Vaughn, F., Sullivan, R., Rubinson, L., Thompson, B. T., Yoon, G., Smoot, E., Rice, T. W., Loftis, L. L., Helfaer, M., et al. (2011) · Pediatrics · doi:10.1542/peds.2011-0774 · Cited by 222 · see citing works
The Initial Response to the Boston Marathon Bombing
Gates, J. D., Arabian, S. S., Biddinger, P. D., Blansfield, J., Burke, P., Chung, S., Fischer, J., Friedman, F. D., Gervasini, A. A., Goralnick, E., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000914 · Cited by 185 · see citing works
Innovation Happens Elsewhere: Open Source as Business Strategy
Goldman, R., & Gabriel, R. P. (2005) · Cited by 138 · see citing works
A framework for evaluating the appropriateness of clinical decision support alerts and responses
McCoy, A. B., Waitman, L. R., Lewis, J. B., Wright, J. A., Choma, D. P., Miller, R. A., & Peterson, J. F. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000185 · Cited by 138 · see citing works
Clinical Research at a Crossroads: The NIH Roadmap
Zerhouni, E. A. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2006.x0016 · Cited by 136 · see citing works
Obstacles facing translational research in academic medical centers
POBER, J. S., NEUHAUSER, C. S., & POBER, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0540lsf · Cited by 132 · cited 1× · see citing works
“Although most institutions recognize the need for growing research informatics support, reductions in grant funding and restricted institutional budgets have diminished the ability of many clinical organizations to hire and retain operations-focused CRI faculty and staff [4,5].”
BackgroundBackus, L. I., Gavrilov, S., Loomis, T. P., Halloran, J. P., Phillips, B. R., Belperio, P. S., & Mole, L. A. (2009) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m3203 · Cited by 104 · see citing works
Ravichandran, T. (2005) · IEEE Transactions on Engineering Management · doi:10.1109/tem.2005.844925 · Cited by 103 · cited 1× · see citing works
“Even with internal and external expectations to collaborate, there remain significant barriers to sharing clinical research software applications [19] and these challenges are not unique to non-profit research communities [20–23].”
Background(2013) · PubMed · Cited by 96 · see citing works
A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates
Slusher, T. M., Olusanya, B. O., Vreman, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501074 · Cited by 89 · cited 1× · see citing works
“The diverse applications of REDCap (Figure 3) include support of basic science research studies [27,28], data collection for clinical trials [29,30], registries and cohort studies [31–35], quality reviews for clinical practice [36–39], comparative effectiveness trials [40–42], patient questionnaires [43–45], clinical…”
BackgroundDispelling myths about rare disease registry system development
Bellgard, M., Béroud, C., Parkinson, K., et al. (2013) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-8-21 · Cited by 75 · see citing works
An i2b2-based, generalizable, open source, self-scaling chronic disease registry
Natter, M. D., Quan, J., Ortiz, D. M., Bousvaros, A., Ilowite, N. T., Inman, C. J., Marsolo, K., McMurry, A. J., Sandborg, C. I., Schanberg, L. E., et al. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001042 · Cited by 73 · cited 1× · see citing works
“, i2b2 [61], OpenMRS [62], and Vivo [63]) and software projects may find such models instructive as well.”
BackgroundReis, S. E., Berglund, L., Bernard, G. R., Califf, R. M., FitzGerald, G. A., & Johnson, P. C. (2010) · Academic Medicine · doi:10.1097/acm.0b013e3181ccc877 · Cited by 70 · cited 1× · see citing works
“Even with internal and external expectations to collaborate, there remain significant barriers to sharing clinical research software applications [19] and these challenges are not unique to non-profit research communities [20–23].”
BackgroundUser Satisfaction With Telehealth
Becevic, M., Boren, S. A., Mutrux, R., Shah, Z., & Banerjee, S. (2015) · The Health Care Manager · doi:10.1097/hcm.0000000000000081 · Cited by 64 · see citing works
Barriers to adoption of software reuse
Sherif, K., & Vinzé, A. (2003) · Information & Management · doi:10.1016/s0378-7206(03)00045-4 · Cited by 63 · see citing works
Petraitienė, R., Petraitis, V., Hope, W. W., Mickiene, D., Kelaher, A. M., Murray, H. A., Mya-San, C., Hughes, J. E., Cotton, M. P., Bacher, J. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00674-08 · Cited by 62 · see citing works
A Comparison of Self-Esteem and Perfectionism in Anorexia Nervosa and Body Dysmorphic Disorder
Hartmann, A. S., Thomas, J. J., Greenberg, J. L., Matheny, N. L., & Wilhelm, S. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000215 · Cited by 57 · see citing works
(2012) · doi:10.2200/s00428ed1v01y201207wbe002 · Cited by 56 · see citing works
Using the PhenX Toolkit to Add Standard Measures to a Study
Hendershot, T. P., Pan, H. H., Haines, J. L., Harlan, W. R., Marazita, M. L., McCarty, C. A., Ramos, E. M., & Hamilton, C. M. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0121s86 · Cited by 54 · see citing works
Mare, I., Hazelhurst, S., Kramer, B., & Klipin, M. (2014) · Applied Clinical Informatics · doi:10.4338/aci-2014-06-cr-0054 · Cited by 50 · cited 1× · see citing works
“REDCap has limited personnel requirements (one support person can easily manage hundreds of projects [48]) but does require typical web infrastructure including one or more secure web servers running PHP, MySQL/MariaDB, and SMTP email services.”
Background(2011) · Europe PMC (PubMed Central) · Cited by 46 · see citing works
Mason, M. J., Light, J. M., Campbell, L. F., Keyser‐Marcus, L., Crewe, S., Way, T., Saunders, H., King, L., Zaharakis, N. M., & McHenry, C. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.06.013 · Cited by 40 · cited 1× · see citing works
“The diverse applications of REDCap (Figure 3) include support of basic science research studies [27,28], data collection for clinical trials [29,30], registries and cohort studies [31–35], quality reviews for clinical practice [36–39], comparative effectiveness trials [40–42], patient questionnaires [43–45], clinical…”
BackgroundClinical research informatics: a conceptual perspective
Kahn, M. G., & Weng, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-000968 · Cited by 40 · see citing works
da Silva, K. R., Costa, R., Crevelari, E. S., Lacerda, M. S., Albertini, C. M. D. M., Filho, M. M., Santana, J. E., Vissoci, J. R. N., Pietrobon, R. S., & de Barros, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071090 · Cited by 40 · see citing works
Lyon, J. A., García-Milian, R., Norton, H., et al. (2014) · Medical Reference Services Quarterly · doi:10.1080/02763869.2014.925379 · Cited by 38 · cited 1× · see citing works
“The diverse applications of REDCap (Figure 3) include support of basic science research studies [27,28], data collection for clinical trials [29,30], registries and cohort studies [31–35], quality reviews for clinical practice [36–39], comparative effectiveness trials [40–42], patient questionnaires [43–45], clinical…”
BackgroundArcher, K. R., Coronado, R. A., Haug, C. M., Vanston, S. W., Devin, C. J., Fonnesbeck, C., Aaronson, O. S., Cheng, J. S., Skolasky, R. L., Riley, L. H., et al. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-325 · Cited by 29 · see citing works
PhenX RISING: real world implementation and sharing of PhenX measures
for the PhenX RISING network, McCarty, C. A., Huggins, W., Aiello, A. E., Bilder, R. M., Hariri, A., Jernigan, T. L., Newman, E. R., Sanghera, D. K., Strauman, T. J., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-16 · Cited by 28 · see citing works
Lense, M., Shivers, C. M., & Dykens, E. M. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00525 · Cited by 26 · cited 1× · see citing works
“The diverse applications of REDCap (Figure 3) include support of basic science research studies [27,28], data collection for clinical trials [29,30], registries and cohort studies [31–35], quality reviews for clinical practice [36–39], comparative effectiveness trials [40–42], patient questionnaires [43–45], clinical…”
BackgroundChoi, B. C. K., & Pak, A. W. P. (2002) · PubMed · Cited by 26 · see citing works
A qualitative model for barriers to software reuse adoption
Sherif, K., & Vinze, A. S. (1999) · International Conference on Interaction Sciences · doi:10.1145/352925.352930 · Cited by 19
da Silva, K. R., Costa, R., Crevelari, E. S., et al. (2013) · PLoS ONE · doi:10.1371/annotation/4df3845a-5099-4b10-b19a-0804cf201345 · Cited by 18 · see citing works
Construction and management of ARDS/sepsis registry with REDCap.
Pang, X., Kozlowski, N., Wu, S., Jiang, M., Huang, Y., Mao, P., Liu, X., He, W., Huang, C., Li, Y., et al. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.09.07 · Cited by 17 · see citing works
A qualitative model for barriers to software reuse adoption
Sherif, K., & Vinzé, A. (1999) · Journal of the Association for Information Systems · doi:10.5555/352925.352930 · Cited by 16 · see citing works
Designing a Public Square for Research Computing
Masys, D. R., Harris, P. A., Fearn, P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004032 · Cited by 16 · see citing works
Self-citationClinical Research Informatics: Survey of Recent Advances and Trends in a Maturing Field
Embi, P. J. (2013) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1638853 · Cited by 14 · see citing works
Eulogy for the clinical research center
Nathan, D. G., & Nathan, D. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88381 · Cited by 14 · cited 1× · see citing works
“Funding support for initial development came from institutional sources as well as the NIH supported General Clinical Research Center (GCRC)[50].”
BackgroundA Comparison of Criterion Standard Methods to Diagnose Acute Heart Failure
Collins, S. P., Lindsell, C. J., Yealy, D. M., et al. (2012) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2012.00288.x · Cited by 13 · see citing works
Embi, P. J., & Payne, P. R. O. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.10.007 · Cited by 13 · see citing works
Practice-Based Innovations: More Relevant and Transportable Than NIH-funded Studies
Etz, R. S., Hahn, K. A., Gonzalez, M. M., Crabtree, B. F., & Stange, K. C. (2014) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2014.06.140053 · Cited by 11 · see citing works
Rose, L. M., Everts, M., Heller, C. A., et al. (2014) · Clinical and Translational Science · doi:10.1111/cts.12175 · Cited by 10 · see citing works
Sewell, J. L., Day, L. W., Tuot, D. S., Alvarez, R., Yu, A., & Chen, A. H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.017 · Cited by 10 · see citing works
A feasibility study to evaluate breast cancer patients’ knowledge of their diagnosis and treatment
Smith, S. M., Balise, R. R., Norton, C., Chen, M. M., Flesher, A. N., & Guardino, A. E. (2012) · Patient Education and Counseling · doi:10.1016/j.pec.2012.08.015 · Cited by 9 · see citing works
Guerrero, L. R., Nakazono, T. T., & Davidson, P. L. (2014) · Clinical and Translational Science · doi:10.1111/cts.12187 · Cited by 7 · see citing works
Crossing the Chasm: Information Technology to Biomedical Informatics
Fahy, B. G., Balke, C. W., Umberger, G. H., Talbert, J., Canales, D. N., Steltenkamp, C. L., & Conigliaro, J. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821452bf · Cited by 5 · see citing works
Anand, V., & Spalding, S. J. (2015) · Studies in health technology and informatics · doi:10.3233/978-1-61499-564-7-554 · Cited by 5 · cited 1× · see citing works
“The diverse applications of REDCap (Figure 3) include support of basic science research studies [27,28], data collection for clinical trials [29,30], registries and cohort studies [31–35], quality reviews for clinical practice [36–39], comparative effectiveness trials [40–42], patient questionnaires [43–45], clinical…”
BackgroundCan small institutes address some problems facing biomedical researchers?
Sheetz, M. P. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-1017 · Cited by 4 · see citing works
The Role of Technology in Translational Science
May, L., Zatorski, C., & Vora, D. (2013) · World Medical & Health Policy · doi:10.1002/wmh3.69 · Cited by 2 · see citing works
Goldman, M. A. (2005) · Genome biology · doi:10.1186/gb-2005-6-10-348 · Cited by 1 · see citing works
Global software development and collaboration
Noll, J., Beecham, S., & Richardson, I. (2010) · ACM Inroads · doi:10.1145/1835428.1835445
(2018) · NASIG Newsletter · doi:10.34068/nasig.33.04.10
Flagged first, then by citations
6 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Committee to Review the Clinical and Translational Science Awards Program at the National Center for Advancing Translational Sciences, Board on Health Sciences Policy, Institute of Medicine, The CTSA Program at NIH: Opportunities for Advancing Clinical and Translational Research, National Academies Press (US), Washington (DC), 2013. http://www.ncbi.nlm.nih.gov/books/NBK144067/ (accessed December 10, 2014).
- Nadan, 2004, Software licensing in the 21st century: Are software licenses really sales, and how will the software industry respond, AIPLA Q. J., 32, 555
Cited by
Sorted by citations
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
McMichael, T. M., Currie, D. W., Clark, S., Pogosjans, S., Kay, M. K., Schwartz, N. G., Lewis, J., Baer, A., Kawakami, V., Lukoff, M. D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2005412 · Cited by 1,322 · see citing works
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016638 · Cited by 1,320 · see citing works
Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17021 · Cited by 1,241 · see citing works
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Tie, J., Cohen, J. D., Lahouel, K., Lo, S. N., Wang, Y., Kosmider, S., Wong, R., Shapiro, J., Lee, M., Harris, S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200075 · Cited by 1,091 · see citing works
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Cavalcanti, A. B., Zampieri, F. G., Rosa, R. G., Azevedo, L. C. P., Veiga, V. C., Avezum, Á., Damiani, L. P., Marcadenti, A., Kawano-Dourado, L. B., Lisboa, T. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2019014 · Cited by 1,082 · see citing works
Vasey, B., Nagendran, M., Campbell, B., Clifton, D. A., Collins, G. S., Denaxas, S., Denniston, A. K., Faes, L., Geerts, B., Ibrahim, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01772-9 · Cited by 1,039 · see citing works
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Woodruff, M. C., Ramonell, R. P., Nguyen, D. C., Cashman, K. S., Saini, A. S., Haddad, N. S., Ley, A. M., Kyu, S., Howell, J. C., Ozturk, T., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00814-z · Cited by 791 · see citing works
Distinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., TABACOF, L. R., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 818 · see citing works
Morgantini, L. A., Naha, U., Wang, H., Francavilla, S., Acar, Ö., Flores, J. M., Crivellaro, S., Moreira, D., Abern, M. R., Eklund, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238217 · Cited by 767 · see citing works
Oster, M. E., Shay, D. K., Su, J. R., Gee, J. M., Creech, C. B., Broder, K. R., Edwards, K. M., Soslow, J. H., Dendy, J. M., Schlaudecker, E. P., et al. (2022) · JAMA · doi:10.1001/jama.2021.24110 · Cited by 671 · see citing works
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Stamatatos, L., Czartoski, J., Wan, Y.-H., Homad, L. J., Rubin, V., Glantz, H., Neradilek, M., Seydoux, E., Jennewein, M. F., MacCamy, A. J., et al. (2021) · Science · doi:10.1126/science.abg9175 · Cited by 557 · see citing works
Vasey, B., Nagendran, M., Campbell, B., Clifton, D. A., Collins, G. S., Denaxas, S., Denniston, A. K., Faes, L., Geerts, B., Ibrahim, M., et al. (2022) · BMJ · doi:10.1136/bmj-2022-070904 · Cited by 665 · see citing works
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
Morin, L., Savale, L., Pham, T. O., Colle, R., Figueiredo, S., Harrois, A., Gasnier, M., Lecoq, A.-L., Meyrignac, O., Noël, N., et al. (2021) · JAMA · doi:10.1001/jama.2021.3331 · Cited by 598 · see citing works
Effectiveness of Telerehabilitation in Physical Therapy: A Rapid Overview
Pamela Serón, S., Oliveros, M. J., Gutiérrez-Arias, R. E., Fuentes-Aspe, R., Torres‐Castro, R., Merino-Osorio, C., Nahuelhual, P., Quiroz, J. I., Jalil, Y., Solano, R., et al. (2021) · Physical Therapy · doi:10.1093/ptj/pzab053 · Cited by 577 · see citing works
Closed-loop neuromodulation in an individual with treatment-resistant depression
Scangos, K. W., Khambhati, A. N., Daly, P. M., Makhoul, G. S., Sugrue, L. P., Zamanian, H., Liu, T. X., Rao, V. R., Sellers, K. K., Dawes, H. E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01480-w · Cited by 535 · see citing works
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Skipper, C. P., Pastick, K. A., Engen, N. W., Bangdiwala, A. S., Abassi, M., Lofgren, S. M., Williams, D. A., Okafor, E. C., Pullen, M. F., Nicol, M. R., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-4207 · Cited by 538 · see citing works
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Ebinger, J. E., Fert‐Bober, J., Printsev, I., Wu, M., Sun, N., Prostko, J. C., Frias, E. C., Stewart, J. L., Eyk, J. E. V., Braun, J. G., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01325-6 · Cited by 524 · see citing works
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Foà, R., Bassan, R., Vitale, A., Elia, L., Piciocchi, A., Puzzolo, M. C., Canichella, M., Viero, P., Ferrara, F., Lunghi, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016272 · Cited by 527 · see citing works
Marjot, T., Moon, A. M., Cook, J. A., Abd-Elsalam, S. M., Aloman, C., Armstrong, M. J., Pose, E., Brenner, E. J., Cargill, T. N., Catana, M.-A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.024 · Cited by 517 · see citing works
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Joyner, M. J., Carter, R. E., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031893 · Cited by 509 · see citing works
Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1065 · Cited by 477 · see citing works
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Joyner, M. J., Wright, R. S., Fairweather, D., Senefeld, J. W., Bruno, K. A., Klassen, S. A., Carter, R. E., Klompas, A. M., Wiggins, C. C., Shepherd, J. R. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140200 · Cited by 472 · see citing works
Cost, K. T., Crosbie, J., Anagnostou, E. A., Birken, C. S., Charach, A., Monga, S., Kelley, E. A., Nicolson, R., Maguire, J. L., Burton, C. L., et al. (2021) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01744-3 · Cited by 468 · see citing works
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
Iversen, K. K., Bundgaard, H., Hasselbalch, R. B., Kristensen, J. H., Nielsen, P. B., Pries‐Heje, M. M., Knudsen, A. D., Christensen, C. E., Fogh, K., Norsk, J. B., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30589-2 · Cited by 425 · see citing works
Emmett, L., Buteau, J. P., Papa, N. P., MOON, D. A., Thompson, J. E., Roberts, M. J., Rasiah, K. K., Pattison, D. A., Yaxley, J. W., Thomas, P. A., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.08.002 · Cited by 434 · see citing works
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
de Souza, W. M., Buss, L., Cândido, D. D. S., Carrera, J., Li, S., Zarebski, A. E., Pereira, R. H. M., Junior, C. A. P., Santos, A. A. D. S., Parag, K. V., et al. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-0928-4 · Cited by 429 · see citing works
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
Deepak, P., Kim, W., Paley, M., Yang, M. M., Carvidi, A. B., Demissie, E., El‐Qunni, A. A., Haile, A., Huang, K., Kinnett, B., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1757 · Cited by 416 · see citing works
Exercise therapy for chronic low back pain
Hayden, J. A., Ellis, J., Ogilvie, R., Malmivaara, A., & van Tulder, M. W. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009790.pub2 · Cited by 589 · see citing works
COVID-19 in solid organ transplant: A multi-center cohort study
Kates, O., Haydel, B., Florman, S., Rana, M., Chaudhry, Z., Ramesh, M., Safa, K., Kotton, C., Blumberg, E., Besharatian, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1097 · Cited by 351 · see citing works
Mehta, N., Kalra, A., Nowacki, A. S., Anjewierden, S., Han, Z., Bhat, P., Rubio, A. C., Jacob, M. S., Procop, G. W., Harrington, S. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1855 · Cited by 400 · see citing works
Joyner, M. J., Bruno, K. A., Klassen, S. A., Kunze, K. L., Johnson, P. W., Lesser, E. R., Wiggins, C. C., Senefeld, J. W., Klompas, A. M., Hodge, D. O., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.028 · Cited by 398 · see citing works
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
Streeck, H., Schulte, B., Kümmerer, B. M., Richter, E., Höller, T., Fuhrmann, C., Bartok, E., Dolscheid‐Pommerich, R., Berger, M., Wessendorf, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19509-y · Cited by 391 · see citing works
Gimbel, M. E., Qaderdan, K., Willemsen, L. M., Hermanides, R. S., Bergmeijer, T. O., de Vrey, E. A., Heestermans, T. A. C. M., Gin, M. T. J., Waalewijn, R. A., Hofma, S. H., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30325-1 · Cited by 354 · see citing works
Osmanov, I. M., Spiridonova, E., Bobkova, P., Gamirova, A., Shikhaleva, A., Andreeva, M., Blyuss, O. B., El-Taravi, Y., DunnGalvin, A., Comberiati, P., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01341-2021 · Cited by 341 · see citing works
Westphaln, K. K., Regoeczi, W., Masotya, M., Vazquez-Westphaln, B., Lounsbury, K., McDavid, L., Lee, H., Johnson, J., & Ronis, S. D. (2021) · MethodsX · doi:10.1016/j.mex.2021.101375 · Cited by 333 · see citing works
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study
Ebbehøj, A. L., Li, D., Kaur, R. J., Zhang, C., Singh, S., Li, T., Atkinson, E. J., Achenbach, S. J., Khosla, S., Arlt, W., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30314-4 · Cited by 341 · see citing works
Joyner, M. J., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., et al. (2020) · medRxiv · doi:10.1101/2020.08.12.20169359 · Cited by 337 · see citing works
New International Guidelines and Consensus on the Use of Lung Ultrasound
Demi, L., Wolfram, F., Klersy, C., Silvestri, A. D., Ferretti, V. V., Muller, M. M., Miller, D. L., Feletti, F., Wełnicki, M. T., Buda, N., et al. (2022) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16088 · Cited by 333 · see citing works
Russell, C. D., Fairfield, C. J., Drake, T. M., Turtle, L. C. W., Seaton, R. A., Wootton, D. G., Sigfrid, L., Harrison, E. M., Docherty, A. B., de Silva, T. I., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00090-2 · Cited by 330 · see citing works
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis
de‐Madaria, E., Buxbaum, J. L., Maisonneuve, P., de Paredes, A. G. G., Zapater, P., Guilabert, L., Vaillo-Rocamora, A., Rodríguez-Gandía, M. Á., Donate, J., Hernández, E. E. L., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202884 · Cited by 343 · see citing works
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
Jacobs, L. G., Paleoudis, E. G., Bari, D. L.-D., Nyirenda, T. L., Friedman, T., Gupta, A., Rasouli, L., Zetkulic, M., Balani, B., Ogedegbe, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243882 · Cited by 328 · see citing works
Grivas, P. D., Khaki, A. R., Wise-Draper, T. M., French, B. C., Hennessy, C., Hsu, C., Shyr, Y., Li, X., Choueiri, T. K., Painter, C., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.02.024 · Cited by 307 · see citing works
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Loyal, L., Braun, J., Henze, L., Kruse, B., Dingeldey, M., Reimer, U., Kern, F., Schwarz, T., Mangold, M., Unger, C., et al. (2021) · Science · doi:10.1126/science.abh1823 · Cited by 284 · see citing works
Young Children’s Use of Smartphones and Tablets
Radesky, J. S., Weeks, H. M., Ball, R., Schaller, A., Yeo, S., Durnez, J., Tamayo-Rios, M., Epstein, M., Kirkorian, H., Coyne, S., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3518 · Cited by 282 · see citing works
Jacques‐Aviñó, C., López‐Jiménez, T., Medina‐Perucha, L., de Bont, J., Gonçalves, A. Q., Duarte‐Salles, T., & Berenguera, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-044617 · Cited by 295 · see citing works
Jamshed, H., Steger, F. L., Bryan, D. R., Richman, J. S., Warriner, A. H., Hanick, C. J., Martin, C. K., Salvy, S.-J., & Peterson, C. M. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.3050 · Cited by 280 · see citing works
Health Behavior Changes During COVID-19 Pandemic and Subsequent “Stay-at-Home” Orders
Knell, G., Robertson, M. C., Dooley, E. E., Burford, K., & Mendez, K. S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176268 · Cited by 280 · see citing works
Randomized Trial of a Generative AI Chatbot for Mental Health Treatment
Heinz, M. V., Mackin, D. M., Trudeau, B. M., Bhattacharya, S., Wang, Y., Banta, H. A., Jewett, A. D., Salzhauer, A. J., Griffin, T. Z., & Jacobson, N. C. (2025) · NEJM AI · doi:10.1056/aioa2400802 · Cited by 287 · see citing works
Kennedy, N. A., Lin, S., Goodhand, J., Chanchlani, N., Hamilton, B., Bewshea, C., Nice, R., Chee, D., Cummings, F. J. R., Fraser, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324789 · Cited by 272 · see citing works
Outpatient Physical, Occupational, and Speech Therapy Synchronous Telemedicine
Tenforde, A. S., Borgstrom, H. E. D., Polich, G. R., Steere, H. K., Davis, I. S., Cotton, K., O’Donnell, M., & Silver, J. K. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001571 · Cited by 268 · see citing works
Klausen, M. K., Jensen, M. E., Møller, M., Le Dous, N., Jensen, A.-M. Ø., Zeeman, V. A., Johannsen, C.-F., Lee, A., Thomsen, G. K., Macoveanu, J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159863 · Cited by 262 · see citing works
Manson, J. J., Crooks, C. J., Naja, M., Ledlie, A., Goulden, B., Liddle, T., Khan, E., Mehta, P., Martin‐Gutierrez, L., Waddington, K. E., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30275-7 · Cited by 289 · see citing works
Effect of the COVID-19 pandemic on medical student career perceptions: a national survey study
Byrnes, Y. M., Civantos, A. M., Go, B., McWilliams, T. L., & Rajasekaran, K. (2020) · Medical Education Online · doi:10.1080/10872981.2020.1798088 · Cited by 255 · see citing works
Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic
Papautsky, E. L., & Hamlish, T. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05828-7 · Cited by 240 · see citing works
Coping styles and mental health in response to societal changes during the COVID-19 pandemic
Gurvich, C., Thomas, N., Thomas, E. H., Hudaib, A.-R., Sood, L., Fabiatos, K., Sutton, K., Isaacs, A., Arunogiri, S., Sharp, G., et al. (2021) · International Journal of Social Psychiatry · doi:10.1177/0020764020961790 · Cited by 238 · see citing works
Hines, S. E., Chin, K. H., Glick, D. R., & Wickwire, E. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020488 · Cited by 243 · see citing works
Baldi, E., Sechi, G. M., Mare, C., Canevari, F., Brancaglione, A., Primi, R., Klersy, C., Palo, A., Contri, E., Ronchi, V., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa508 · Cited by 234 · see citing works
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19
the STOP-COVID Investigators, Shaefi, S., Brenner, S. K., Gupta, S., O’Gara, B., Krajewski, M. L., Charytan, D. M., Chaudhry, S., Mirza, S. H., Peev, V., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06331-9 · Cited by 237 · see citing works
Acute kidney injury in patients treated with immune checkpoint inhibitors
Gupta, S., Short, S., Sise, M. E., Prosek, J. M., Madhavan, S. M., Soler, M. J., Ostermann, M., Herrmann, S. M., Abudayyeh, A., Anand, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003467 · Cited by 239 · see citing works
Webb, G. J., Marjot, T., Cook, J. A., Aloman, C., Armstrong, M. J., Brenner, E. J., Catana, M.-A., Cargill, T. N., Dhanasekaran, R., García‐Juárez, I., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30271-5 · Cited by 237 · see citing works
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
Whitworth, H., Sartain, S. E., Kumar, R., Armstrong, K. W., Ballester, L. S., Betensky, M., Cohen, C. T., Díaz, R., Diorio, C. J., Goldenberg, N. A., et al. (2021) · Blood · doi:10.1182/blood.2020010218 · Cited by 217 · see citing works
The Environmental Influences on Child Health Outcomes (ECHO)-Wide Cohort
Knapp, E. A., Kress, A., Parker, C. B., Page, G. P., McArthur, K., Gachigi, K. K., Alshawabkeh, A. N., Aschner, J. L., Bastain, T. M., Breton, C. V., et al. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad071 · Cited by 218 · see citing works
Dandachi, D., Geiger, G., Montgomery, M. W., Karmen-Tuohy, S., Golzy, M., Antar, A. A. R., Llibre, J. M., Camazine, M. N., de Santiago, A. D., Carlucci, P. M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1339 · Cited by 215 · see citing works
Taber, A., Christensen, E., Lamy, P., Nordentoft, I., Prip, F., Lindskrog, S. V., Birkenkamp‐Demtröder, K., Okholm, T. L. H., Knudsen, M., Pedersen, J. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18640-0 · Cited by 211 · see citing works
Khoury, R. S., Bernstein, P. S., DeBolt, C. A., Stone, J. L., Sutton, D. M., Simpson, L. L., Limaye, M. A., Roman, A. S., Fazzari, M. J., Penfield, C. A., et al. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004025 · Cited by 212 · see citing works
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells
Minervina, A. A., Pogorelyy, M. V., Kirk, A. M., Crawford, J. C., Allen, E. K., Chou, C., Mettelman, R. C., Allison, K., Lin, C.-Y., Brice, D. C., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01184-4 · Cited by 210 · see citing works
Fisher, K. A., Tenforde, M. W., Feldstein, L. R., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6936a5 · Cited by 211 · see citing works
Impact of COVID ‐19 stay‐at‐home orders on weight ‐ related behaviours among patients with obesity
Almandoz, J. P., Xie, L., Schellinger, J. N., Mathew, M. S., Gazda, C., Ofori, A., Kukreja, S. S., & Messiah, S. E. (2020) · Clinical Obesity · doi:10.1111/cob.12386 · Cited by 208 · see citing works
Ribeiro, A. C. D. M., Aikawa, N. E., Saad, C. G. S., Yuki, E. F. N., Pedrosa, T. D. N., Fusco, S. R. G., Rojo, P. T., Pereira, R. M. R., Shinjo, S. K., Andrade, D. C. O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01469-5 · Cited by 197 · see citing works
A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent
Lawrence, C. E., Dunkel, L., McEver, M., Israel, T. L., Taylor, R. J., Chiriboga, G., Goins, K. V., Rahn, E. J., Mudano, A. S., Roberson, E. D., et al. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.30 · Cited by 205 · see citing works
Self-citationMasi, A., Diaz, A. M., Tully, L. A., Azim, S. I., Woolfenden, S. R., Efron, D., & Eapen, V. (2021) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15285 · Cited by 199 · see citing works
Aguilar-Farías, N., Toledo-Vargas, M., Miranda-Marquez, S., Cortínez-O’Ryan, A., Cristi‐Montero, C., Rodríguez‐Rodríguez, F., Martino-Fuentealba, P., Okely, A. D., & Cruz, B. D. P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010176 · Cited by 197 · see citing works
Systematic Development of Patient Decision Aids: An Update from the IPDAS Collaboration
Witteman, H. O., Maki, K. G., Vaisson, G., Finderup, J., Lewis, K. B., Steffensen, K. D., Beaudoin, C., Comeau, S., & Volk, R. J. (2021) · Medical Decision Making · doi:10.1177/0272989x211014163 · Cited by 196 · see citing works
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions
Kalchiem‐Dekel, O., Connolly, J. G., Lin, I., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.07.2169 · Cited by 196 · see citing works
Brenner, M. J., Pandian, V., Milliren, C. E., Graham, D. A., Zaga, C. J., Morris, L., Bedwell, J. R., Das, P., Zhu, H., Allen, J. L. Y., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.04.054 · Cited by 191 · see citing works
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing
Jehi, L. E., Ji, X., Milinovich, A., Erzurum, S., Rubin, B. P., Gordon, S., Young, J. B., & Kattan, M. W. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.580 · Cited by 190 · see citing works
Cognitive Motor Dissociation in Disorders of Consciousness
Bodien, Y. G., Allanson, J. E., Cardone, P., Bonhomme, A., Carmona, J. C., Chatelle, C., Chennu, S., Conte, M. M., Dehaene, S., Finoia, P., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2400645 · Cited by 190 · see citing works
“Study staff from each site entered data into a central REDCap (Research Electronic Data Capture) 26 database housed at Icahn School of Medicine at Mount Sinai, the Data Coordinating Center.”
Machado, P., Lawson‐Tovey, S., Strangfeld, A., Mateus, E. F., Hyrich, K. L., Gossec, L., Carmona, L., Rodrigues, A., Raffeiner, B., Duarte, C., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221490 · Cited by 181 · see citing works
Buck, B. H., Hill, M. D., Quinn, F. R., Butcher, K., Menon, B. K., Gulamhusein, S. S., Siddiqui, M. M., Coutts, S. B., Jeerakathil, T., Smith, E. E., et al. (2021) · JAMA · doi:10.1001/jama.2021.6128 · Cited by 184 · see citing works
Worldwide Survey of COVID-19–Associated Arrhythmias
Coromilas, E. J., Kochav, S., Goldenthal, I. L., Biviano, A., Garan, H., Goldbarg, S., Kim, J.-H., Yeo, I., Tracy, C. M., Ayanian, S., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009458 · Cited by 179 · see citing works
Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
Dangouloff, T., Vrščaj, E., Servais, L., Osredkar, D., Adoukonou, T., Aryani, O., Barišić, N., Bashiri, F. A., Bastaki, L. A., Benitto, A., et al. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.03.007 · Cited by 177 · see citing works
Orchard, F., Gregory, A. M., Gradisar, M., & Reynolds, S. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13288 · Cited by 175 · see citing works
The Impact of Migration Status on Adolescents’ Mental Health during COVID-19
Pieh, C., Dale, R., Jesser, A., Probst, T., Plener, P. L., & Humer, E. C. (2022) · Healthcare · doi:10.3390/healthcare10010176 · Cited by 178 · see citing works
Chuong, M. D., Bryant, J. M., Mittauer, K. E., et al. (2020) · Practical Radiation Oncology · doi:10.1016/j.prro.2020.09.005 · Cited by 174 · see citing works
Ilvemark, J. F. K. F., Hansen, T. M., Goodsall, T. M., Seidelin, J. B., Al-Farhan, H., Allocca, M., Begun, J., Bryant, R. V., Carter, D., Christensen, B., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab173 · Cited by 173 · see citing works
Heath, M., Hvass, A. M. F., & Wejse, C. M. (2023) · Journal of Migration and Health · doi:10.1016/j.jmh.2023.100162 · Cited by 175 · see citing works
Macchi, Z. A., Koljack, C. E., Miyasaki, J. M., Katz, M., Galifianakis, N., Prizer, L. P., Sillau, S., & Kluger, B. M. (2019) · Annals of Palliative Medicine · doi:10.21037/apm.2019.10.01 · Cited by 166 · see citing works
Antommaria, A. H. M., Gibb, T. S., McGuire, A. L., Wolpe, P. R., Wynia, M. K., Applewhite, M. K., Caplan, A. L., Diekema, D. S., Hester, D. M., Lehmann, L. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1738 · Cited by 165 · see citing works
SARS‐CoV‐2 infection as a trigger of autoimmune response
Sacchi, M. C., Tamiazzo, S., Stobbione, P., Agatea, L., Gaspari, P. D., Stecca, A., Lauritano, E. C., Roveta, A., Tozzoli, R., Guaschino, R., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12953 · Cited by 165 · see citing works
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Kennedy, N. A., Goodhand, J., Bewshea, C., Nice, R., Chee, D., Lin, S., Chanchlani, N., Butterworth, J. R., Cooney, R., Croft, N. M., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324388 · Cited by 198 · see citing works
Cohen, C., Kleynhans, J., Gottberg, A. V., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., Plessis, M. D., Carrim, M., Buys, A., et al. (2021) · doi:10.1101/2021.07.20.21260855 · Cited by 153 · see citing works
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
Ip, A., Berry, D. A., Hansen, E., Goy, A. H., Pecora, A. L., Sinclaire, B., Bednarz, U., Marafelias, M., Berry, S. M., Berry, N., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237693 · Cited by 162 · see citing works
Chang, K., Khandpur, N., Neri, D. A., Touvier, M., Huybrechts, I., Millett, C. J., & Vamos, E. P. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2021.1573 · Cited by 165 · see citing works
Mahil, S. K., Dand, N., Mason, K. J., Yiu, Z. Z. N., Tsakok, T., Meynell, F., Coker, B., McAteer, H., Moorhead, L., Mackenzie, T., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.007 · Cited by 153 · see citing works
Digital health interventions to support family caregivers: An updated systematic review
Zhai, S., Chu, F., Tan, M., Chi, N., Ward, T. M., & Yuwen, W. (2023) · Digital Health · doi:10.1177/20552076231171967 · Cited by 173 · see citing works
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Files, J. K., Boppana, S., Perez, M. D., Sarkar, S., Lowman, K. E., Qin, K., Sterrett, S., Carlin, E., Bansal, A., Sabbaj, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140491 · Cited by 155 · see citing works
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy, N. A., Goodhand, J., Bewshea, C., Nice, R., Chee, D., Lin, S., Chanchlani, N., Butterworth, J. R., Cooney, R. M., Croft, N. M., et al. (2021) · Figshare · doi:10.17863/cam.66211 · Cited by 153 · see citing works
Shouval, R., Tomas, A. A., Fein, J. A., Flynn, J. R., Markovits, E., Mayer, S., Afuye, A. O., Alperovich, A., Anagnostou, T., Besser, M. J., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.02143 · Cited by 155 · see citing works
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Esper, F. P., Adhikari, T. M., Tu, Z. J., Cheng, Y., El-Haddad, K., Farkas, D. H., Bosler, D. S., Rhoads, D. D., Procop, G. W., Ko, J. S., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac411 · Cited by 154 · see citing works
See, I., Lale, A., Marquez, P. L., Streiff, M. B., Wheeler, A. P., Tepper, N. K., Woo, E. J., Broder, K. R., Edwards, K. M., Gallego, R., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4502 · Cited by 152 · see citing works
- Authors
- Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., & Duda, S. N.
- Affiliations
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Harris, Paul A.
- Venue
- Journal of Biomedical Informatics
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 95
- Pages
- 103208
- ISSN
- 1532-0464 (ISSN-L)
- PMC
- PMC7254481
- OpenAlex
- W2944434778
- Semantic Scholar
- aea266d1d66f01c9141385a7e1baf6d1599dcae9
- Cited by
- 24,013
- References
- 63
- Citations by year
- 2026: 3706 · 2025: 4752 · 2024: 4657 · 2023: 3779 · 2022: 3249 · 2021: 2604 · 2020: 1153 · 2019: 70 · 2018: 2 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 2198.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Biomedical Informatics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH/NCATS (UL1 TR002243)
- Topics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Social Sciences › Decision Sciences › Information Systems and Management › Scientific Computing and Data Management
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- REDCap, research data management tools, consortium model, software adoption
- MeSH terms
- Humans, Medical Informatics, Software, Information Dissemination, Biomedical Research, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-15.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-15.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review